Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06218706 · ClinicalTrials.gov registry record · NA

LIFU for Treatment for Refractory Opioid Use Disorder

A NA study of Opioid Use Disorder, sponsored by Ali Rezai.

Recruiting
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT06218706 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Ali Rezai. The registered enrollment target is 34 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06218706, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Ali Rezai.

RECRUITING
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, double-blind, sham-controlled, partial crossover study investigating LIFU targeting the NAc and VC for participants with severe, treatment refractory OUD.

Conditions Studied

Interventions

  • DEVICE Low Intensity Focussed Ultrasound

Study Locations (1)

West Virginia

  • WVU Rockefeller Neuroscience Institute - Morgantown

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2024-05-09
Est. Completion 2028-03-01
Phase NA

Sponsor

Ali Rezai

4 total trials

What the Registry Record Tells You About NCT06218706

The ClinicalTrials.gov registry entry for NCT06218706 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Ali Rezai, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Low Intensity Focussed Ultrasound is the first listed.

NCT06218706 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.

Frequently Asked Questions

What is clinical trial NCT06218706 about?

NCT06218706 is a clinical study titled "LIFU for Treatment for Refractory Opioid Use Disorder". This is a randomized, double-blind, sham-controlled, partial crossover study investigating LIFU targeting the NAc and VC for participants with severe, treatment refractory OUD.

What is the current status of trial NCT06218706?

This trial is currently recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2024-05-09. Estimated completion is 2028-03-01.

What conditions does trial NCT06218706 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT06218706?

The interventions under investigation include: Low Intensity Focussed Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT06218706?

This trial is sponsored by Ali Rezai, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06218706 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.